NCT07290426尚未招募不适用
A Prospective Clinical Study Evaluating Pulse Dye Laser on Clearance of Vascular Indications
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 40
- 主要终点
- Clearance of Vascular Lesion
研究概览
简要总结
This is a clinical study to evaluate the safety and performance of the Vbeam Pro Laser System for the treatment of vascular indications, including rosacea and port wine stain birthmarks.
详细描述
Study Design This is a non-randomized, open-label clinical study evaluating clinical treatments with the Vbeam Pro system for the treatment of vascular indications, including rosacea and port wine stain birthmarks. There are two phases of this study:
Phase I: Safety
- Screening and Enrollment Visit
- Up to Three (3) Treatment Visits (with treatment intervals from 2 weeks to 6 weeks).
- 7 Day (+/- 5 days) Follow Up Visit following Each Treatment Session (may be a virtual telephone or video visit)
- Additional follow-up visits may be required per the discretion of the principal investigator to assess safety and healing progression
Phase II: Safety, Efficacy, and Optimization of Treatment Parameters
- Screening and Enrollment Visit
- Treatment visits are limited to up to eight (8) study treatments (with treatment intervals from 1 week to 8 weeks).
- Follow-up #1 (4 weeks - 8 weeks)
- Follow-up #2 (8 weeks - 16 weeks) (optional)
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy subjects aged 18 years or older
- •Presence of one or more vascular lesion, cutaneous lesion, or other dermatological condition deemed fit for treatment
- •Able and willing to comply with the treatment/follow-up schedule and comply with all study (protocol) requirements.
- •Willing to provide signed, informed consent to participate in the study
- •Willing to have photographs and images taken of the treated areas to be used in evaluations, publications, presentations, and marketing materials
排除标准
- •Pregnant or planning to become pregnant, having given birth less than 3 months prior to enrollment into the study, and/or breast feeding
- •Known photosensitivity to 595nm or 1064 nm light
- •History of light-induced seizure disorders
- •Severe unstable concurrent conditions, such as unstable cardiac disorders
- •Use of implanted medical device including pacemakers, cardioverters and other implantable devices or fillers per investigator discretion (consultation with physicians prior to treatment is required)
- •Use of photosensitizing medications (medications that introduce photosensitivity or medications within or above the 595 nm wavelength, refer to Candela's list of drugs that may cause photosensitivity)
- •Tattoos (including decorative, permanent makeup and radiation port tattoos) in the intended study treatment area (595nm use only)
- •Active Herpes Simplex Virus (HSV) in the intended treatment area unless treated with prophylactic medication
- •The intended treatment area has significant sun exposure within the past 2 weeks or self-tanner has been applied to the treatment area
- •In the opinion of the Investigator, the subject is unwilling or unable to adhere to the study requirements or is otherwise unsuitable for the study
结局指标
主要结局
Clearance of Vascular Lesion
时间窗: Baseline to Follow-up #1 (up to 72 weeks)
Evaluation of clearance of vascular indications following treatment series as indicated by a minimum 1-point improvement on the validated Investigator's Global Assessment (IGA) Scale at study endpoint relative to baseline as rated by the principal investigator.
次要结局
- Investigator Global Aesthetic Improvement Scale(Baseline to Follow-up #1 (up to 72 weeks))
- Subject Satisfaction Scale(Baseline to Follow-up #1 (up to 72 weeks))
研究者
相似试验
已完成
4 期
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic RosaceaErythematotelangiectatic RosaceaNCT04153188Candela Corporation34
已完成
2 期
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye LaserCutaneous Lupus ErythematosusNCT00523588University of Pennsylvania10
已完成
不适用
Laser Therapy in the Isotretinoin-Induced SacroiliitisNCT07264153Uşak University36
已完成
不适用
Pulsed Dye Laser in Treating Superficial Basal Cell CarcinomasBasal Cell CarcinomaNCT02125669Hautklinik Darmstadt100
尚未招募
不适用
Micropulse Laser Photocoagulation in Diabetic Macular EdemaNCT07266597Sohag University50